GI Genius™ Module 300

by Cosmo Artificial Intelligence - AI  · Based in Ireland → — Powered by artificial intelligence to help you detect early, treat early.
Colorectal Surgery Gastroenterology Oncology

Contact vendor for pricing
Regulatory Status Disclosed

Overview

The GI Genius™ intelligent endoscopy module, including the Module 300, is a groundbreaking, first-to-market computer-aided polyp detection system powered by artificial intelligence (AI). Developed by Cosmo Artificial Intelligence – AI and globally distributed by Medtronic, it is designed to assist endoscopists in real-time detection of colonic mucosal lesions, such as polyps and adenomas, during standard white light endoscopy examinations.

The system works by continuously scanning the video stream from the endoscope camera. When it identifies a potential lesion, it automatically highlights the abnormality with a green box and provides a short, low-volume audible signal, enhancing the physician’s visualization and improving the thoroughness of the examination. Studies have shown that the GI Genius™ module can increase the Adenoma Detection Rate (ADR) by up to 14.4%, contributing to earlier detection and improved patient outcomes in the fight against colorectal cancer.

The GI Genius™ module is compatible with all standard white light endoscopes and is intended to be used as an adjunct to colonoscopy procedures, not as a replacement for clinical decision-making or endoscopist assessment.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Real-time AI-assisted polyp and lesion detection during colonoscopy
  • Computer-aided visualization enhancement for mucosal lesions
  • Increases Adenoma Detection Rate (ADR) by up to 14.4%
  • High sensitivity rate of 99.7% with less than 1% false positives
  • Compatible with all standard white light endoscopes
  • Identifies and marks abnormalities with a green box and audible signal
  • Aids in detecting polyps of various sizes, shapes, and morphologies
  • Supports early detection of colorectal cancer

Use Cases

  • Colorectal cancer screening and surveillance colonoscopies
  • Real-time detection of colonic mucosal lesions (polyps, adenomas)
  • Improving endoscopist performance and accuracy in lesion detection
  • Reducing the risk of missed polyps during endoscopic examinations
  • Enhancing patient care and outcomes in gastrointestinal disease management

What Physicians Need to Know

Polyp Detection During Colonoscopy
The GI Geniusu2122 module is a computer-aided polyp detection system powered by AI, designed to enhance visualization and aid in detecting colorectal polyps of various sizes, shapes, and morphologies. It operates in real-time, automatically identifying and marking abnormalities consistent with polyps, including small flat ones, with a green box on the screen. The system boasts a 99.7% sensitivity rate with less than 1% false positives and can reduce the number of missed polyps by approximately 50%. It performs real-time analysis 82% faster than an endoscopist.
Real-Time Endoscopy AI
As a real-time computer-aided detection (CADe) system, the GI Geniusu2122 module processes images using advanced algorithms to highlight precancerous lesions with a visual marker. It functions as an 'ever-vigilant second observer' during standard white-light endoscopy examinations, assisting endoscopists in detecting colonic mucosal lesions in real-time.
Adenoma Detection Rate Improvement
The GI Geniusu2122 module has been shown to significantly increase the Adenoma Detection Rate (ADR), with studies demonstrating an absolute increase of up to 14.4% and a 30% relative increase. This improvement in ADR is crucial, as every 1% increase in ADR is correlated with a 3% decrease in the risk of interval cancer. The system significantly lowers the miss rate of both adenomas and polyps, with the adenoma miss rate (AMR) being substantially reduced (15.5% vs 32.4%) when GI Genius is utilized.
Procedure Documentation
Recent software updates, such as ColonPROu2122, introduce features that provide procedural highlights, aiming to automate physicians' workflows and reduce administrative burdens in documentation. Medtronic is actively collaborating with Modernizing Medicineu00ae (ModMed) to integrate GI Geniusu2122 with gGastrou00ae EHR software, enabling real-time, AI-generated data transfer for more efficient documentation. Additionally, a quality module (CADq) offers automated measurements of key quality metrics.
Quality Metrics Tracking
The GI Geniusu2122 module contributes to improving critical quality metrics, particularly the Adenoma Detection Rate (ADR), which is a key indicator for colonoscopy quality. The new quality module (CADq) provides automated measurements for essential quality metrics, including inspection times, cecum detection, and bowel cleanliness, optimizing colonoscopy practice.
Endoscopy System Compatibility
The GI Geniusu2122 intelligent endoscopy module is designed for seamless and universal compatibility with existing endoscopy equipment and workflows. It can be easily integrated with major brands of endoscopic processors, including Olympus, Fujifilm, and Pentax, by simply connecting to the existing endoscope, video processor, and display monitor.
Physician Tip

The GI Geniusu2122 Module 300 serves as a valuable AI-powered adjunct to colonoscopy, acting as an 'ever-vigilant second observer' to enhance polyp detection, especially for subtle or flat lesions that might otherwise be missed. While it significantly improves the Adenoma Detection Rate (ADR) and reduces miss rates, it is crucial to remember that the system is an aid and does not replace clinical judgment, diagnosis, or the need for histopathological sampling. Physicians should continue to exercise their expertise for decision-making regarding lesion characterization and removal. Be aware that the device has not been studied in patients with inflammatory bowel disease (IBD), a history of colorectal cancer, or previous colonic resection, and its performance may be affected by mucosal irregularities. Leverage its real-time feedback to optimize examination thoroughness and consider its potential to streamline documentation through emerging EHR integrations.

The GI Geniusu2122 module offers seamless integration with existing endoscopy setups, connecting directly to standard endoscopy towers, high-definition endoscopes, video processors, and display monitors. It is compatible with major endoscopic processor brands such as Olympus, Fujifilm, and Pentax, allowing for immediate AI benefits without altering current procedural workflows. Future integrations are being developed, including collaborations with Electronic Health Record (EHR) systems like ModMed's gGastrou00ae software, to enable real-time data transfer for automated documentation. The AI Accessu2122 platform also supports the development of third-party applications.

Details

Category Gastroenterology AI
Pricing Contact vendor for pricing
DeploymentHardware and software module integrated as an adjunct to standard white light endoscopy systems.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The GI Genius™ intelligent endoscopy module (including Module 300) received FDA marketing authorization on April 12, 2021, through the De Novo premarket review pathway (K241887). It was the first device to use AI based on machine learning to assist clinicians in detecting lesions in the colon in real time during a colonoscopy.

Integrations
EHR Not specified
Specialties Colorectal Surgery, Gastroenterology, Oncology

What the Web Says

The Medtronic GI Geniusu2122 Module 300 is an AI-powered endoscopy system designed to assist physicians in detecting colorectal polyps during colonoscopies. It functions as a real-time second observer, enhancing the video stream with graphical markers around areas of interest identified by its computer-aided detection (CADe) algorithm. The system has been shown to significantly improve adenoma detection rates (ADR), which is crucial for preventing colorectal cancer.

Overall: Positive

Strengths

  • Increases adenoma detection rate (ADR) significantly, with studies showing up to a 14.4% absolute increase and a 12% relative increase.
  • Reduces the miss rate of colorectal polyps and adenomas by approximately 50% compared to standard colonoscopy.
  • Identifies small, flat, and subtle polyps that might otherwise be missed by the human eye.
  • Provides real-time analysis and flags potential problem areas without modifying or delaying the endoscopy video stream.
  • Universally compatible with major existing brands of endoscopic processors (Olympus, Fujifilm, Pentax).
  • Can help decrease the risk of interval colorectal cancer; each 1% increase in ADR reduces this risk by 3%.

Limitations

  • May not significantly improve the detection of advanced adenomas or sessile serrated lesions.
  • Its impact may be less significant among highly experienced endoscopists in real-world scenarios compared to controlled study conditions.
  • There is a concern about potential over-reliance on the AI system and a possible drop in ADR if physicians become accustomed to using it and then it's removed.
  • Can lead to a small increase in the amount of healthy tissue biopsied.
  • The technology can be expensive, leading some centers with already good ADRs to not yet incorporate it.
  • Some physicians note that the AI can occasionally miss polyps or highlight areas that are not a concern.

Based on reviews from: Medtronic, PMC, Medical Device Network, Newsroom | Medtronic, UCHealth, Colon Cancer Foundation, The AdventHealth Blog, ENDOSCOPY (Shria Kumar, MD, MSCE and Gottumakkala S. Raju, MD, FACG, FASGE), PubMed, GI Alliance, Mayo Clinic School of Continuous Professional Development, University Hospital, PR Newswire, Reddit (r/Gastroenterology, r/science)

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate GI Genius™ Module 300

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Stock Titan
Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates
Cosmo Pharmaceuticals reported strong preliminary unaudited 2024 results, including u20ac185 million in non-recurring revenues from Medtronic and FDA 510(k) clearance for the GI Geniusu2122 Module 300 hardware. The GI Geniusu2122 installed base continued to grow in 2024, and the module 300, powered by Nvidia IGX, received FDA 510(k) clearance.
2025-01
Nasdaq
Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms
Cosmo Pharmaceuticals announced the smooth rollout of the GI Geniusu2122 Module 300 across customer sites, confirming its robustness and scalability. The company also initiated a clinical usability study integrating the Medtronic GI Geniusu2122 AI endoscopy module with Apple Vision Pro during live colonoscopy procedures.
2026-01
Innolitics
Q2 2026 AI/ML FDA Clearances and De Novos
The FDA authorized 86 AI/ML devices in Q2 2026, including the GI Geniusu2122 Module 300 (GGM300-US) for Gastroenterology/Urology, which received 510(k) clearance. This report highlights the continued growth of AI in medical devices, with radiology still dominating but other specialties emerging.
2026-07
Medtronic News
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care.
Medtronic announced innovations and collaborations at the Genius Summit 2024, highlighting the GI Geniusu2122 Module 300 as an open compute engine for AI applications built on NVIDIA IGX. The flagship application, ColonPROu2122, aims to reduce miss rates in colorectal cancer screening through polyp detection and characterization.
2024-04
TMX Newsfile
Cosmo Achieves Robust Financial Performance in H1 2024 and Confirms Its Full Year Guidance
Cosmo Pharmaceuticals reported strong H1 2024 results, including a $100 million upfront payment from Medtronic related to an expanded AI-driven partnership. The new GI Geniusu2122 module 300, powered by Nvidia IGX, has been submitted to the FDA for clearance.
2024-07
Public Technologies (PUBT)
Cosmo Pharmaceuticals Half-Year Report 2024
Cosmo Pharmaceuticals' Half-Year Report 2024 highlights the submission of the new GI Geniusu2122 module 300, powered by Nvidia IGX, to the FDA for clearance. The report also notes the continued growth of the GI Geniusu2122 installed base and the development of additional features.
2024-06
RegWatch
FDA 510(k) Clearance: GI Geniusu2122 Module 300 (GGM300-US);ColonPROu2122 US (CPRO403S-US)
Cosmo Artificial Intelligence - Ai, Ltd. received FDA 510(k) clearance (K261369) for GI Geniusu2122 Module 300 (GGM300-US) and ColonPROu2122 US (CPRO403S-US) on May 29, 2026. The product is classified under Gastroenterology, Urology with product code QNP.
2026-05
RevMed
GI Geniusu2122 Module 300 (GGM300-US)
RevMed lists the GI Geniusu2122 Module 300 (GGM300-US) by LINKVERSE SRL, describing it as a GI Geniusu2122 system with ColonPROu2122 software. It is categorized under Gastroenterology & Urology as a Gastrointestinal Lesion Software Detection System.
unknown

Videos

Product demos, reviews, and walkthroughs for GI Genius™ Module 300.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

The GI Geniusu2122 Module 300 integrates seamlessly by connecting between the endoscope and the display, processing video frames in real-time. It overlays detection markers on suspicious regions, providing AI assistance without disrupting the physician's established workflow or adding visible latency.
The GI Geniusu2122 Module 300 received FDA 510(k) clearance in April 2021, making it the first AI system cleared for real-time polyp detection during colonoscopy. It is restricted to prescription use and is not intended to replace clinical decision-making or function as a standalone diagnostic device.
While GI Genius was the first FDA-cleared AI system for real-time polyp detection, other commercially available AI-assisted systems include Fujifilm's CAD-EYE and Pentax's Discovery AI. These systems also aim to enhance polyp and adenoma detection during colonoscopy procedures.
Specific pricing details are not publicly disclosed, but Medtronic offers service plans that cover hardware, software enhancements, and technical support. Practices may also acquire units through programs like the ASGE Health Equity Assistance Program, which includes a 3-year capital agreement.
The GI Geniusu2122 Module 300 has not been studied in patients with inflammatory bowel disease (IBD), a history of colorectal cancer, or previous colonic resection. Its performance may also be negatively impacted by mucosal irregularities stemming from certain underlying diseases.
Clinical studies have demonstrated that the GI Geniusu2122 Module 300 can increase the adenoma detection rate (ADR) by up to 14.4% and reduce adenoma miss rates by approximately 50%. This improvement in ADR is associated with a 3% decrease in the risk of interval cancer for every 1% increase.

Related Tools

GI Genius Module
Cosmo Artificial Intelligence - Ai, Ltd.
Gastroenterology AI
The GI Genius™ intelligent endoscopy module is an AI-powered system designed to assist physicians in the real-time detection of colorectal polyps during colonoscopy, acting as a "second set of eyes" to enhance visualization and improve detection rates.
Cologuard / Cologuard Plus
Exact Sciences
Gastroenterology AI
Cologuard and Cologuard Plus are FDA-approved, non-invasive stool DNA colorectal cancer screening tests from Exact Sciences for average-risk individuals aged 45 and older. Cologuard Plus offers enhanced accuracy and fewer false positives. These at-home tests detect DNA markers and blood in stool to identify early-stage colorectal cancer.
Deep Capsule
Digestaid - Artificial Intelligence Development SA
Gastroenterology AI
Deep Capsule is an AI software tool that assists in reviewing capsule endoscopy images by detecting and differentiating lesions, stratifying hemorrhagic potential, and highlighting clinically relevant frames for physician validation.
Pure-Vu
Motus GI
Gastroenterology AI
The Pure-Vu System is an FDA-approved device that facilitates intra-procedural cleansing of the GI tract to improve visualization during colonoscopies and gastroscopies, especially in cases of inadequate bowel preparation or GI bleeding.
aScope Gastro
Ambu
Gastroenterology AI
The Ambu aScope Gastro is a sterile, single-use gastroscope with advanced imaging and design features for a variety of endoscopic procedures in the upper GI tract, offering portability and eliminating reprocessing.
CADDIE™ Computer-Aided Detection (CADe) Device
Odin Medical Ltd. (an Olympus Corporation company)
Clinical Decision Support & Reference
CADDIE™ is the first cloud-based AI technology to receive FDA clearance, designed to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures. This AI tool, developed by Odin Medical Ltd., an Olympus Corporation company, supports real-time polyp detection and characterization, improves adenoma detection rates, and integrates seamlessly into existing clinical workflows.

See all Gastroenterology AI tools →

More from Cosmo Artificial Intelligence – AI

ColonPRO™ 4.0 (CPRO40S-US)
Cosmo Artificial Intelligence - AI
Gastroenterology AI
ColonPRO™ 4.0 is an FDA-cleared, AI-powered computer-assisted detection system that integrates with standard colonoscopy equipment to help endoscopists identify colonic polyps and adenomas in real-time, improving detection rates during screening and surveillance procedures.
GI Genius
Cosmo Artificial Intelligence - AI
Gastroenterology AI
GI Genius is the first FDA-cleared AI-powered endoscopy module that assists physicians in real-time polyp detection during colonoscopies to improve colorectal cancer screening and surveillance.
GI Genius Module
Cosmo Artificial Intelligence - Ai, Ltd.
Gastroenterology AI
The GI Genius™ intelligent endoscopy module is an AI-powered system designed to assist physicians in the real-time detection of colorectal polyps during colonoscopy, acting as a "second set of eyes" to enhance visualization and improve detection rates.
GI Genius™ Module 100
Cosmo Artificial Intelligence - AI
Gastroenterology AI
The GI Genius™ Module 100 is an FDA-cleared, AI-powered computer-aided detection system that assists physicians in real-time detection of colonic polyps and adenomas during colonoscopy, enhancing visualization and improving detection rates.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.